PMVP — PMV Pharmaceuticals, Inc. catalysts
Next verified catalyst
2026-08-15 — The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mu · official source ↗
Upcoming
| Date | Event | Company | Drug | Official source & verification |
|---|---|---|---|---|
| 2026-08-15 in 2mo
ESTIMATED |
READOUT
The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP5
Phase 1/2 · Advanced Solid Tumor, Advanced Malignant Neoplasm |
PMVP PMV Pharmaceuticals, Inc. | rezatapopt, pembrolizumab |
ClinicalTrials.gov ↗
✓ Source-checked 2026-06-22
Sponsor-projected date — can change
|